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Along with many others of my generation at the Yale School of Medicine
and the New Haven Hospital, I owe a great debt to Grover Powers as an
inspiring teacher, friend, and benefactor. The invitation to give the Grover
Powers lecture at Yale had a special emotional significance, therefore,
and it is with a sense of great privilege that I address you this afternoon.
I do not consider the primary purpose of this lecture as an occasion to
honor Grover Powers. He has received so many honors under such im-
portant auspices that anything that I could add today would be relatively
minor. The major purpose is to remind ourselves and succeeding classes of
students at Yale of the great heritage which Grover Powers has given us-
his teachings, counseling, and personal example which have contributed
so much to the development of pediatrics in this country and to the
emergence of the Yale University School of Medicine as an important in-
fluence in medical education and practice.
In Osler's felicitous words, "The great possession of any university is
its great names-not its wealth, nor the number of its schools but the men
who have trodden in its service the thorny road through toil." Grover
Powers is one of the great possessions of this school and his contributions
continue to have relevance to the problems that we face today. One of the
current preoccupations and concerns of members of clinical departments
in our medical schools is the balancing of the importance of fundamental
research against the responsibilities of the department for teaching and
for the care of patients in the teaching hospital. This is not a new problem
and I should like to remind you that within a relatively small department
Grover Powers developed two major research laboratories: in electrolyte
physiology under Daniel C. Darrow and in microbiology and immunology
under James D. Trask. His department was noted for its devotion to the
teaching of medical students and residents, and also of physicians in this
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State interested in maintaining continued excellence in the care of children.
The extraordinary dedication of Grover Powers to the care of patients and
the success with which he transmitted this dedication to his students is
legendary.
Inasmuch as Grover Powers was directly responsible for my start in
medical research, I have chosen to devote this Grover Powers lecture to a
review of our research efforts in a single area. Exciting contributions in
the biological sciences have been made in the elucidation of the structure
of biologically important molecules and in the understanding of the
mechanisms that link the structure of the genetic material, DNA, with the
structure of specific proteins. As physiologists, however, we are interested
in molecular function and in structure as it is expressed in function. As
physicians we are hopeful that knowledge of molecular structure and
function can be applied to the understanding, diagnosis, and treatment of
the abnormalities of physiologic states which are present in our patients.
Although studies of the action of molecules that regulate cell functions may
seem of only theoretic interest, in the long run such information will con-
tribute to our understanding of disease. For many years my wife and I
have been interested in unraveling the role of two molecules that control
the concentration of Ca++ ion in the body fluids: parathyroid hormone and
vitamin D, and this report represents our joint research.
Aurbach and Rasmussen have both succeeded in purifying parathyroid
hormone."' It is a single chain polypeptide of a molecular weight of about
8,600, although somewhat smaller peptides have been split off which still
have biological activity. The amino acid composition is known but the exact
sequences and the precise molecular configuration have not yet been de-
termined. The purified peptide acts on the renal tubule to reduce the amount
of filtered phosphate which is retrieved by the tubule cells thus increasing
the excretion of phosphate in the urine. There are differences of opinion
whether this action is through the blocking of phosphate transport from
tubular lumen to cell to peritubular fluid or through increased transport
from peritubular fluid to cell to lumen. At the moment this need not concern
us. Another action of this peptide is to activate bone cells, osteoclasts
and osteocytes, so that through their increased metabolic activity local
changes result that effect the dissolution of the bone crystals in contact with
the cell surfaces and the proteolysis of the demineralized collagen. The
biochemical mechanism through which parathyroid hormone produces these
alterations of phosphate transport and of bone cell activity is unknown.
Rasmussen' has suggested that parathyroid increases inorganic phosphate
uptake by mitochondria in vitro and that its primary action is to alter mem-
brane properties with respect to divalent ion transport. The specificity of
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this mitochondrial reaction has been disputed since Aurbach has reported
that peptides which are physiologically inert when given to the animal
have the same action on mitochondrial systems.
In contrast to parathyroid hormone, vitamin D, the structure of which
has been known for over 30 years, is a relatively simple organic molecule
which is usually classified in the group of steroids. Ever since highly con-
centrated and purified preparations of vitamin D have been available it has
been recognized that this steroid in pharmacologic doses can be used as
substitution therapy in patients with hypoparathyroidism. In these doses,
which are more than 100 times the physiologic requirement, vitamin D
restores to normal the serum calcium and phosphorus concentrations of
the hypoparathyroid subject and to all intents and purposes replaces the
missing parathyroid hormone. Parathyroid hormone, on the other hand,
cannot replace vitamin D since vitamin D deficiency occurs in patients
with intact parathyroids. Although parathyroid hyperplasia occurs in re-
sponse to deficiency of calcium ion, this parathyroid overactivity does not
rectify the abnormal physiologic state in vitamin D depleted subjects.
Indeed the parathyroid overactivity is thought by some to intensify the
abnormality of bone mineralization in vitamin D deficiency rickets.
The hypocalcemia of vitamin D deficiency in the face of parathyroid
hyperplasia is a familiar phenomenon and in the rachitic or osteomalacic
subject had been ascribed to structural changes in the poorly mineralized
bone which supposedly made the bone calcium less available. In order to
reinvestigate this problem we produced vitamin D deficiency in rats with-
out rickets.8 This animal can be depleted of vitamin D and rickets prevented
by feeding a suitable proportion of calcium and phosphate in the diet.
The bones of such rats are histologically normal and bone ash content is
not reduced. There is some reduction of body growth in comparison with
vitamin D fed controls. The blood serum analyses show a striking hypo-
calcemia while serum phosphorus concentrations remain in the high normal
range of young rats (Table 1). The parathyroid glands of these rats are
enlarged. This suggested to us that the tissues of the vitamin D deficient
rats were unresponsive to parathyroid hormone. As shown in Table 1, when
doses of parathyroid extract that produce hypercalcemia and hypo-
phosphatemia in normal rats were given to the Vitamin D depleted animals,
no effect was seen. When the animals were given a small dose of vitamin D
(500 units) 48 hours before the injection of parathyroid extract, the
expected hypercalcemia and depression of serum phosphate followed the
parathyroid hormone treatment. We concluded that vitamin D was required
for the responsiveness of the end organs to physiologic amounts of para-
thyroid hormone. These studies were repeated with purified parathyroid
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hormone including determinations of urine phosphate excretion.4 Again the
hypocalcemic vitamin D depleted rats failed to respond to parathyroid
hormone either by a rise in serum calcium or by an increase in urine phos-
phate and decrease of serum phosphate. Repletion with vitamin D restored
the normal response to parathyroid hormone (Table 2). These experiments
have been repeated by Rasmussen with essentially similar results. Ras-
mussen has pointed out, however, that parathyroidectomy in the vitamin D
deficient rat causes a further increase of serum phosphate but no change
TABLE 1. VITAMIN D AND RESPONSE TO PARATHYROID EXTRAcT
Serum
Group Ca P
mg/100ml.
Deficient 5.9 10.2
Deficient + P.T.E.* 5.7 9.7
Vitamin D** 10.9 13.2
Vitamin D** + P.T.E.* 13.3 8.2
* Parathyroid extract (Lilly). 100 units injected subcutaneously at 24 and 6 hours
before blood sample.
**500 units of vitamin DI orally 72 hours before blood sample (48 hours before
first P.T.E. injection).
Underlined figures are significantly different from values in rats not receiving
parathyroid extract.
in serum calcium.' His interpretation of the data is that vitamin D is
required for the response of bone cells to parathyroid hormone but that
the effect of parathyroid hormone on phosphate transport can occur to some
degree in the absence of vitamin D. Studies of the interrelation of vitamin D
and parathyroid hormone have been made by DeLuca, et al.' using separated
kidney mitochondria. Under conditions in which ATP and oxidisable sub-
strate are available, mitochondria accumulate calcium and inorganic phos-
phate and the accumulated ions are liberated when the high energy phos-
phate bonds are exhausted. The rate of liberation or mobilization of accumu-
lated calcium from the mitochondria is greatly retarded if preparations
are obtained from tissues of vitamin D deficient rats and the rate is
accelerated by addition of calciferol or parathyroid hormone in vitro. The
parathyroid hormone effect, however, is obtained only if vitamin D is
present in the system either by addition or by virtue of the treatment with
vitamin D of the animal from which the mitochondria were obtained.
Another type of in vitro study also indicates the role of vitamin D in
sensitizing tissues to parathyroid hormone. Raisz7 incubated embryonic rat
bone in tissue culture in a medium containing rat serum to which para-
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thyroid hormone was added. In the presence of this hormone, cell prolifera-
tion occurred to a much greater extent than in control preparations without
parathyroid hormone. If the rat serum added to the culture medium was
obtained from vitamin D deficient rats rather than normal animals, the
addition of parathyroid hormone did not produce cell proliferation.
The uptake of inorganic phosphate by mitochondrial suspensions is
accelerated by addition of parathyroid hormone to the incubation medium
and this effect is obtained even though thetissues supplying the mitochondria
TABLE 2. VITAMIN D AND RESPONSE TO PURIFIED PARATHYROID HoRMONE
Serum
Group Ca P Urine P
_mg/100 ml. mg/6 hrs.
Deficient 7.9 9.2 1.9
Deficient + P.T.H.* 7.9 8.8 2.5
Vit. D** 9.6 10.7 3.1
Vit. D** + P.T.H.* 12.5 5.5 9.2
* Parathyroid hormone equivalent to 100 units injected subcutaneously 6 hours before
blood sample. Urine collected during this 6 hour interval.
** Vitamin D2, 100 units 24 hours before blood sample.
Underlined figures are significantly different from values in rats not receiving
parathyroid hormone.
are removed from vitamin D deficient rats. The physiologic significance of
this reaction has been questioned, however, because of the high concentra-
tions of parathyroid peptide used in this experiment and because peptides
that are physiologically inert in the intact animal will also produce this
effect on isolated mitochondria.
In vitamin D deficient infants with rickets, parathyroid extract does not
raise the serum calcium nor induce phosphaturia until after vitamin D
treatment has been given. It is probable, however, that the unresponsiveness
of the vitamin D depleted subject to parathyroid hormone is not complete
and is dose dependent. In dogs and in rats of a strain other than the ones
used by Rasmussen and ourselves, Bartter8 and Toverud9 respectively
have found a response to parathyroid extract despite apparent deficiency of
vitamin D. However, the vitamin D deficient dogs and rats are hypocalcemic
with concomitant parathyroid hyperplasia, and in a recent report Raisz
and his co-workers have shown that the enlarged parathyroid glands of
such hypocalcemic rats are physiologically active in demineralizing bone
under in zvtro conditions so that their ineffectivness in the intact animal
almost certainly represents relative unresponsiveness of the end organ
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in the absence of vitamin D.10 It is likely that vitamin D sensitizes specific
target tissues to parathyroid hormone and the inhibitory effect of vitamin D
deficiency may be overcome by increasing the hormone concentration greatly
above the physiologic level. It is of interest that Stanbury' has extended
FIG. 1. Everted loop of rat small intestine preparatory to immersion in buffer
solution. The mucosal surface is on the outside and solutes are transported across the
mucosal layer and are collected in the fluid filling the serosal lined interior of the
loop. (Taken from Harrison and Harrison."3)
this concept to explain the hypocalcemia and the marked parathyroid
hyperplasia of subjects with renal insufficiency. He has postulated that
these patients are vitamin D resistant and are relatively unresponsive to
parathyroid hormone unless given doses of vitamin D much in excess of
ordinary requirements. It is well-known that large doses of vitamin D
given to patients with chronic renal insufficiency will restore the serum
calcium to normal and reverse the bone changes of secondary hyper-
parathyroidism.
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Further examination of the specific biochemical reactions influenced by
vitamin D and parathyroid hormone is required. In the instance of vitamin
D, studies making use of surviving segments of small intestine in vitro
have been informative. In the technique developed by Wilson and Wise-
manU these segments are everted so that the mucosa is on the outside and
the ends tied off to form closed sacs. We have modified the method using
open ended everted loops1" (Fig. 1). The mucosal epithelium of these
everted sacs or loops forms the outside surface and continues to pump
solutes from the luminal surface across the serosal pole of the cell into
the interstitial fluid from which the solutes diffuse into the space lined
TABLE 3. EFFECT OF VITAMIN D ON CONCENTRATIVE TRANSPORT OF
CALCIUM BY RAT SMALL INTESTINE
Cs/Cm*
Intestinal Vit. D Vit. D.**
Segment Deficient Treated
Duodenum 1.06 3.39
* Ratio of concentrations of Ca"5 in loop contents (Cs) and mucosal fluid (Cm) at
end of period of incubation. Initial ratio = 1.
** 1,000 units of vitamin D given to rats 72 hours before intestine removed for
preparation of loops.
by the serosal cell layer. The transported solutes thus accumulate in the
serosal fluid within the loop at a higher concentration than in the mucosal
solution and the efficiency of the transport system can be measured by the
ratio of the concentration of the ion or molecule in serosal fluid to its con-
centration in the fluid bathing the mocosal surface. When the transport of
calcium is studied by this method it is found that intestinal loops from
vitamin D deficient rats have a greatly diminished capacity to transport
calcium in comparison with loops from animals given vitamin D (Table 3).
This transport of calcium against a concentration difference is an energy
requiring process. However the movement of calcium across the intestinal
mucosa can be separated into two stages: the first, which is not directly
dependent on metabolic energy, is the diffusion of calcium into the mucosal
cell at the luminal surface and the second is the energy requiring active
transport of calcium against a concentration difference from cell into the
interstitial fluid. To examine whether vitamin D influences the first step,
everted loops of rat small intestine were studied" under conditions in which
metabolic energy production was inhibited either by low temperature or
addition of a metabolic inhibitor, N-ethyl maleimide. In these experiments
the intestinal mucosa acted as a semi-permeable membrane rather than an
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active transport system and the permeability of the membrane to calcium
was being tested. Varying concentrations of calcium labeled with Ca45
were placed on the mucosal surface whereas the serosal fluid initially con-
tained no calcium. At the end of the period of incubation the quantity of
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FIG. 2. Calcium transport in everted intestinal loops from which mucosa has been
removed, incubated at 50 C. *-* loops from vitamin D-treated rats, o----o
loops from vitamin D-deficient rats. Each point represents the average value of
determinations on 4-8 loops. (Taken from Harrison and Harrison.'4)
calcium entering the serosal solution was determined. Intestinal loops
from vitamin D deficient and vitamin D treated rats were studied and the
importance of the mucosal cell layer was also examined by use of prepara-
tions from which the mucosa had been mechanically scraped off. If we first
look at one of the latter preparations incubated at 5° C. (Fig. 2), there is a
strict linear relation between the calcium entering the serosal phase and
the initial concentration of calcium on the mucosal surface which is com-
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patible with diffusion. No difference between loops from vitamin D deficient
and vitamin D treated rats is found in this preparation from which mucosal
cells have been removed. Similar studies with loops with intact mucosa
(Fig. 3) show the same linear relation between mucosal calcium concen-
tration and calcium entering the serosal phase but there is now a definite
effect of vitamin D treatment in increasing the quantity of calcium diffusing
across the intestinal wall. The results at 370C. with a metabolic inhibitor
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FIG. 3. Calcium transport in everted jejunal intestinal loops with intact mucosa
incubated at 50 C. *-e* loops from vitamin D-treated rats, o----o loops from
vitamin D-deficient rats. The vertical lines indicate ± standard error of mean. (Taken
from Harrison and Harrison.')
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present are similar (Fig. 4 and 5). We have concluded that the intestinal
mucosal cells present a diffusion barrier to calcium, and that vitamin D,
in effect, alters the permeability of the membrane to calcium so that the
diffusion barrier is reduced. The net effect of vitamin D on calcium trans-
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FIG. 4. Calcium transport in everted intestinal loops from which mucosa has been
removed, incubated at 37' C, 0.5 mM/liter n-ethyl maleimide in medium. *-* loops
from vitamin D-treated rats, o ----o loops from vitamin D-deficient rats.
(Taken from Harrison and Harrison.14)
port could depend on the more rapid penetration of calcium into the
cell, which increases the amount of calcium available to the energy de-
pendent transport system. It is interesting to compare this action of vitamin
D on calcium transport with the action of d-aldosterone on sodium trans-
port in an in vitro system. Sharp and Leaf"5 have suggested that the major
action of aldosterone on the toad bladder is "manifest as an increase in the
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permeability to sodium of the mucosal surface of the single layer of epithelial
cells."
During the past few years the theory has been proposede that certain
hormones produce their effects through a genetic mechanism, i.e., the
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FIG. 5. Calcium transport in everted jejunal intestinal loops with intact mucosa
incubated at 37° C. 0.5 mM/liter n-ethyl maleimide in medium, .-. loops from
vitamin D-treated rats, o---o loops from vitamin D-deficient rats. The vertical
lines indicate ± standard error of mean. (Taken from Harrison and Harrison.")
hormone activates specific gene loci in the DNA molecule which promotes
the production of new messenger RNA and ultimately the synthesis of
specific enzymes. One type of evidence used to support this theory is the
inhibition of hormone effects by prior administration of actinomycin
D. This antibiotic, which has some value as an antitumor agent, is a com-
plex polypeptide which complexes with DNA at the guanine locus and thus
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blocks the action of RNA polymerase in forming messenger RNA mole-
cules on the DNA template. Actinomycin D does inhibit the physiologic
activity of vitamin D, preventing both the increase of serum calcium and
the increased transport of calcium across the intestinal wall. Figure 6
shows the inhibition of the serum calcium raising effect of vitamin D by
II-
10-
8
I::
I
ACTINOMYCIN D AND RESPONSE OF SERUM CALCIUM
TO VITAMIN D
/ __-~~~~~~~ ~72
0/
/ 3, 6 /
/
_-~~~ O ~
M_-~~~~~~~~~
I I I I I I
10 20 30 40 50 60
HOURS POST VITAMIN
70 80 90
D
FIG. 6. The effect of actinomycin D in blocking the action of vitamin D on serum
calcium concentrations of vitamin D-deficient rats. The solid line shows the increase
in serum calcium level with time following a single oral dose of 50,000 units of
vitamin D2 to hypocalcemic vitamin D-deficient rats. The dashed line shows the serum
calcium concentrations of rats given the same vitamin D treatment but also injected
with actinomycin D 1 ,ug/gm body weight either simultaneously with the vitamin D
or at the intervals after vitamin D, shown by the figures under the points which
represent hours. The serum calcium concentration of the actinomycin D-treated rats
was measured in every instance 18 hours after the injection of the compound. The
initial points of both curves give the serum values of rats not given vitamin D. Each
point represents the average of determinations on 4 to 8 rats.
actinomycin D treatment in experiments in which actinomycin was given at
various intervals after a dose of vitamin D and serum calcium concentra-
tions measured 18 hours after the actinomycin injection. Treatment of
the vitamin D deficient rat with actinomycin D reduces the serum calcium
levels below the abnormally low levels due to vitamin D deficiency and in-
404
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hibits the vitamin D effect in raising the serum calcium concentrations.
This inhibition is almost complete unless the vitamin D is given between 6
to 18 hours before the actinomycin D injection. It is also important to
emphasize that actinomycin D decreases the active intestinal transport of
calcium in the vitamin D deficient rat below the already low levels due
to lack of vitamin D (Table 4). The Cs/Cm values of much less than one
after actinomycin D treatment, indicates that transfer of calcium across
the mucosal surface is reduced to negligible amounts so that the mucosal
concentration r7em;ains unchanged whereas the Ca45 concentration is serosal
TABLE 4. INHIBITION OF; INTESTINAL TRAI4SPbRT OF CALCIPM BY
ACTINOMYCIN .(VITAMIN D DEFICIENT kATs)
Treatment Conc. transport of calcium
_______ _ (Cs/Cm)
None 1.1 ± 0.11
Actinomycin D*-3 hrs. 0.69 ± 0.13
Actinomycin D*-7 hrs. 0.54 ± 0.04
(Vit. D**>4 hrs.)
Vitamin D**>4 hrs. 2.1 ± 0.05
* Actinomycin D 1 jug/gm. body weight injected subcutaneously at stated time
before intestine removed for in vitro incubation.
**Vitamin D, 50,000 units given orally at stated time before intestine removed.
fluid diminishes below the initial value owing to diffusion into the intestinal
wall. The effect of actinomycin D is to inhibit the calcium transport system
itself either by some direct toxic effect or by blocking the regeneration of
a labile component. There is no evidence that vitamin D operates through
a genetic mechanism by inducing mRNA and protein synthesis. Its
mechanism of action may be its direct combination with some component
of cell membranes.
Some understanding of the possible link between the action of vitamin
D in increasing the rate of penetration of calcium into cells and its
sensitization of cells to parathyroid hormone action may be afforded by
studies of intestinal transport of inorganic phosphate."7 By use of the
everted intestinal loop the transport of inorganic phosphate across the
intestinal wall against a concentration difference can be demonstrated
in vitro (Fig. 7). This transport, like other active transport systems, re-
quires metabolic energy. The concentration differences developed by this
sytem are much less in preparations from vitamin D deficient rats than in
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those from vitamin D treated animals (Fig. 8). The effect of vitamin D
on this transport function is apparently mediated through calcium ion
since removal of calcium from the buffer solution in which the loops are
incubated reduces the concentration ratio of phosphate between serosal
APs FM -a_ 46.6 -3a1444-4.4+7.9
CS/Cm 10.99 10.00 23.20
6
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FIG. 7. Concentrative transport of inorganic phosphate across wall of everted
intestinal loops in vitro. The horizontal dashed line indicates the initial concentration
of phosphate in both mucosal and serosal fluids. Height of the hatched column indicates
concentration of phosphate in mucosal fluid at end of incubation, height of the hollow
column indicates concentration of phosphate in serosal fluid at end of incubation.
The ratio, Cs/Cm, is shown at the top of each experiment. (Taken from Harrison
and Harrison.'7)
and mucosal fluids and if calcium ion is completely removed by addition
of a low concentration of a chelating agent, EDTA, the transport of phos-
phate ceases and the effect of vitamin D is therefore abolished (Fig. 9).
There are, therefore, direct effects of vitamin D and secondary effects
presumably mediated through the action of vitamin D in increasing the
concentration of calcium in the cell surface or within the cell. We can
speculate that the sequence of reactions in the physiologic response to
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parathyroid hormone includes a step in which calcium or other divalent
cation is a necessary cofactor. In the absence of vitamin D, the concen-
tration of divalent cation in a cell compartment is too low to permit the
parathyroid hormone initiated chain of reactions to occur except possibly
to a limited extent in the presence of very high concentrations of hormone.
EFFECT OF VITAMIN D ON CONCENTRATION
DIFFERENCE OF INORGANIC PHOSPHATE
ACROSS INTESTINAL WALL AS RELATED
TO SEGMENT OF SMALL INTESTINE
FROM WHICH LOOP WAS PREPARED
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I~~~~~
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INTESTINAL LOCATION
FIG. 8. Effect of Vitamin D treatment of rats upon the concentrative transport of
inorganic phosphate across wall of everted intestinal loop in vitro. Cs/Cm ratios are
averages of values of 4 to 15 loops. * loops from vitamin D-deficient rats, o loops
from vitamin D-treated rats. The vertical lines indicate + standard error of mean.
(Taken from Harrison and Harrison.'7)
In the absence of hormone, high concentrations of vitamin D may trigger
the cell response by increasing intracellular calcium above the usual
physiologic concentration. This could explain the action of high doses of
vitamin D in the hypoparathyroid subject. This, of course, is speculative.
We do not as yet know the specific biochemical reaction that is respon-
sible for the physiologic action of parathyroid hormone. Although the
action of vitamin D appears to be at the cell surface with a resultant
increase in the permeability of the cell membrane to calcium, the mechanism
of this change in cell membrane properties is also undetermined. The data
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presented do suggest that vitamin D acts as a regulatory agent in certain
cell processes by governing the rate of movement of calcium and possibly
other divalent cations across the plasma membrane or the membranes of
cell organelles. Parathyroid hormone may also function by altering the
16I
14z
12
10
8-
6-
4.
2-
I.-
0 2
C& MM/ L.
0.I
N.. EDTA mM/L.
FIG. 9. Interrelation of calcium and vitamin D effect on concentrative transport of
phosphate. Three series of experiments are diagrammed from left to right in which
the medium contained 2mM/liter Ca, 0 Ca and 0.1 mM/liter Na2EDTA respectively.
Points are averages of Cs/Cm values from 7 to 39 everted intestinal loops from the
jejunum of vitamin D-deficient rats (@) and vitamin D-treated rats (o). The vertical
lines indicate standard error of mean. (Taken from Harrison and Harrison.'7)
properties of membranes that control the movement of divalent ions into
specific compartments of the cell. It will remain for future investigators
to determine whether these ideas will be fruitful in reaching the sought-
after goal of determining the exact action of these specific molecules in
controlling those cellular functions that regulate the flow of Ca++ into body
fluids and into bone mineral.
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